JHS Svendgaard Laboratories Limited (NSE:JHS)
India · Delayed Price · Currency is INR 13.03
-0.02 (-0.15%)
Jul 17, 2025, 2:28 PM IST
NSE:JHS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 919.97 | 707.98 | 848.15 | 862.52 | 1,008 | Upgrade |
Other Revenue | 28.77 | 20.95 | 63.45 | 9.59 | 2.05 | Upgrade |
| 948.74 | 728.93 | 911.59 | 872.11 | 1,010 | Upgrade | |
Revenue Growth (YoY) | 30.16% | -20.04% | 4.53% | -13.63% | -28.72% | Upgrade |
Cost of Revenue | 610.42 | 458.32 | 631.4 | 620.72 | 705.19 | Upgrade |
Gross Profit | 338.32 | 270.61 | 280.2 | 251.39 | 304.51 | Upgrade |
Selling, General & Admin | 101.16 | 97.64 | 120.49 | 117.54 | 107.38 | Upgrade |
Other Operating Expenses | 248.49 | 154.92 | 186.44 | 105.2 | 121.02 | Upgrade |
Operating Expenses | 429.15 | 316.03 | 367.1 | 293.26 | 300.95 | Upgrade |
Operating Income | -90.83 | -45.42 | -86.9 | -41.87 | 3.55 | Upgrade |
Interest Expense | -5.65 | -4.25 | -4.98 | -12.7 | -12.4 | Upgrade |
Interest & Investment Income | - | 5.61 | 9.9 | 21.99 | 8.3 | Upgrade |
Currency Exchange Gain (Loss) | - | -1.2 | 9 | 6.53 | -7.35 | Upgrade |
Other Non Operating Income (Expenses) | - | -126.02 | 133.33 | 5.15 | 16.08 | Upgrade |
EBT Excluding Unusual Items | -96.48 | -171.27 | 60.35 | -20.9 | 8.18 | Upgrade |
Gain (Loss) on Sale of Investments | - | 2.85 | 0.7 | 1.53 | 2 | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.02 | 25.4 | 15 | -0.5 | Upgrade |
Other Unusual Items | -28.59 | 6.95 | -183.62 | 5.4 | - | Upgrade |
Pretax Income | -125.08 | -161.46 | -97.18 | 1.03 | 9.68 | Upgrade |
Income Tax Expense | 72.37 | 6.29 | -54.28 | 43.92 | -3.75 | Upgrade |
Earnings From Continuing Operations | -197.44 | -167.75 | -42.89 | -42.89 | 13.42 | Upgrade |
Minority Interest in Earnings | - | 13.12 | 2.37 | 2.37 | -1.44 | Upgrade |
Net Income | -197.44 | -154.64 | -40.52 | -40.52 | 11.98 | Upgrade |
Net Income to Common | -197.44 | -154.64 | -40.52 | -40.52 | 11.98 | Upgrade |
Shares Outstanding (Basic) | 83 | 78 | 78 | 64 | 61 | Upgrade |
Shares Outstanding (Diluted) | 83 | 78 | 78 | 64 | 62 | Upgrade |
Shares Change (YoY) | 6.27% | - | 21.89% | 4.34% | 1.22% | Upgrade |
EPS (Basic) | -2.37 | -1.97 | -0.52 | -0.63 | 0.20 | Upgrade |
EPS (Diluted) | -2.37 | -1.97 | -0.52 | -0.63 | 0.20 | Upgrade |
Free Cash Flow | -157.11 | -401.17 | 89.43 | -158.75 | 36.96 | Upgrade |
Free Cash Flow Per Share | -1.89 | -5.12 | 1.14 | -2.47 | 0.60 | Upgrade |
Gross Margin | 35.66% | 37.12% | 30.74% | 28.83% | 30.16% | Upgrade |
Operating Margin | -9.57% | -6.23% | -9.53% | -4.80% | 0.35% | Upgrade |
Profit Margin | -20.81% | -21.21% | -4.45% | -4.65% | 1.19% | Upgrade |
Free Cash Flow Margin | -16.56% | -55.04% | 9.81% | -18.20% | 3.66% | Upgrade |
EBITDA | -11.33 | 12.8 | -26.74 | 28.65 | 60.52 | Upgrade |
EBITDA Margin | -1.19% | 1.76% | -2.93% | 3.28% | 5.99% | Upgrade |
D&A For EBITDA | 79.5 | 58.21 | 60.17 | 70.52 | 56.96 | Upgrade |
EBIT | -90.83 | -45.42 | -86.9 | -41.87 | 3.55 | Upgrade |
EBIT Margin | -9.57% | -6.23% | -9.53% | -4.80% | 0.35% | Upgrade |
Effective Tax Rate | - | - | - | 4264.47% | - | Upgrade |
Revenue as Reported | 948.74 | 751.13 | 961.36 | 956.42 | 1,083 | Upgrade |
Advertising Expenses | - | 2.85 | 17.79 | 2.44 | 2.72 | Upgrade |
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.